Intuitive receives CE mark for transvaginal use of da Vinci SP system
September 20, 2026
The approval allows the da Vinci SP system to be utilised in more women’s health procedures across Europe.
The approval allows the da Vinci SP system to be utilised in more women’s health procedures across Europe.
Scientists at the University of Galway have taken part in a first-in-human study of stroke patients using a thin wire fitted with sensors to assess and map their clots.
Researchers at City of Hope, one of the largest and most advanced cancer research and treatment organizations in the country, led the development of a new investigational blood test that could detect pancreatic cancer at its earliest stages, when the disease is more treatable and potentially curable.
In the sickest COVID-19 patients, SARS-CoV-2 doesn’t just cause severe damage by directly infecting airway cells. The virus can also trigger hyperinflammation—a cycle in which immune cells themselves become infected, stop fighting the virus and instead trigger high levels of inflammation throughout the lungs.
Researchers at Wake Forest University School of Medicine have identified a protein that may help an aggressive form of breast cancer spread to the brain and escape the body’s immune defenses.
Researchers have uncovered a previously unknown gene that causes resistance to a leading blood cancer drug, as well as several genes that accelerate lymphoma growth, using a powerful new CRISPR activation library.
Minimally invasive surgery is a promising approach that allows doctors to intervene inside the body through small incisions, typically using advanced instruments. These can include small robotic instruments controlled by a surgeon, cameras or devices that measure specific signals.
NORCROSS, Ga., Sept. 18, 2026 /PRNewswire/ — Koning Health, a global leader in advanced breast imaging technology, today announced that the Koning Breast CT System has been successfully included in the Australian Register of Therapeutic Goods (ARTG), marking an important regulatory milestone for the company’s expansion into the Australian market.
DeepHealth has announced FDA 510(k) clearance for Chest XRay, one of the first FDA-cleared chest X-ray computer-aided detection (CADe) solutions built on a foundation model that detects and localizes suspected thoracic abnormalities on chest radiographs. The clearance marks a significant step in the company’s vision of bringing intelligence into every stage of the imaging experience.
Researchers have developed a 3D map of an ovary for the first time, enabling a deeper understanding of how and when oocytes — immature eggs — are activated. Published in the journal Nature Aging, the team believes their findings have important implications for human reproductive health, as well as opening the door to future studies.